BCL2 and neoplasm: Similar to the preclinical studies, PD analyses on the tumour biopsies found that selinexor decreased protein expression as measured by immunofluorescent staining of BCL-2, BCL-6, and c-Myc, and restored nuclear localization of XPO1 cargo such as p53 [57].